Judith de Vos-Geelen

Maastricht University Medical Centre

Netherlands

Research Interests

Explore related searches

Professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (15)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (10)

Zoltan Czigany

GERMANY

View details

Sander Rensen

Associate professor

University of Maastricht

NETHERLANDS

View details

Martijn W J Stommel

Radboud University Medical Center

NETHERLANDS

View details

Janine Ziemons

University of Maastricht

NETHERLANDS

View details

Sven Arke Lang

University Hospital Essen

GERMANY

View details

Nadine Gaisa

RWTH Aachen University

GERMANY

View details

John Penders

Associate professor

University of Maastricht

NETHERLANDS

View details

David Barnett

University of Maastricht

NETHERLANDS

View details

Robin van geel

University of Maastricht

NETHERLANDS

View details

Ardy van Helvoort

Associate Professor

University of Maastricht

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Judith de Vos-Geelen

Research Interests

Explore related searches

Contact this professor

Articles (15)

Prebiotic fibre mixtures counteract the manifestation of gut microbial dysbiosis induced by the chemotherapeutic 5-Fluorouracil (5-FU) in a validated in vitro model of the colon

Altered biodistribution of [68Ga]Ga-DOTA-TOC during somatostatin analogue treatment

ASO Author Reflections: Nationwide Experience on Locally Advanced Pancreatic Cancer Surgery After Induction Chemotherapy in the Netherlands: A Stepping Stone for the PREOPANC-4 Trial

Insights into synchronous peritoneal metastases from hepatobiliary origin: Incidence, risk factors, treatment, and survival from a nationwide database

Nationwide evaluation of pancreatic cancer networks ten years after the centralization of pancreatic surgery

Impact of network treatment in patients with resected pancreatic cancer on use and timing of chemotherapy and survival

Population-based impact of COVID-19 on incidence, treatment, and survival of patients with pancreatic cancer

Fecal levels of SCFA and BCFA during capecitabine in patients with metastatic or unresectable colorectal cancer

Insights into synchronous peritoneal metastases from hepatobiliary origin: Incidence, risk factors, treatment, and survival from a nationwide database

Impact of network treatment in patients with resected pancreatic cancer on use and timing of chemotherapy and survival

The Role of Intestinal Microbiota in Metastatic Colorectal Cancer Patients Treated With Capecitabine

PD-1+ T-Cells Correlate with Nerve Fiber Density as a Prognostic Biomarker in Patients with Resected Perihilar Cholangiocarcinoma

Impact of multicentre diagnostic workup in patients with pancreatic cancer on repeated diagnostic investigations, time-to-diagnosis and time-to-treatment: A nationwide analysis

Age and prognosis in patients with pancreatic cancer: a population-based study

Intestinal Microbiota in Postmenopausal Breast Cancer Patients and Controls

Collaborators (10)

Zoltan Czigany

Sander Rensen

Martijn W J Stommel

Janine Ziemons

Sven Arke Lang

Nadine Gaisa

John Penders

David Barnett

Robin van geel

Ardy van Helvoort

Make your next move.